DAPSA versus cDAPSA: Do we need to use CRP? | Annals of the Rheumatic Diseases
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis | Scientific Reports
Original article
Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA Criteria - Rheumatology Advisor
Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
Frontiers | Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature
Advances in the management of psoriatic arthritis | Nature Reviews Rheumatology
Radiographic Progression in Psoriatic Arthritis Achieving a Good Response to Treatment: Data Using Newer Composite Indices of Disease Activity - Helliwell - 2018 - Arthritis Care & Research - Wiley Online Library
UvA-DARE (Digital Academic Repository)
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY | Annals
PDF) Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World | Fausto Salaffi - Academia.edu
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases
Descriptive statistics for DAPSA on weeks 12 and 24 | Download Table
PDF) Comparison of disease activity measures in early psoriatic arthritis in usual care
Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text
ANNUAL MEETING 2019
DAPSA (Disease Activity in PSoriatic Arthritis) Score DAPSA = TJ + SJ + CRP + Activity + Pain =
Home
The Patient's Perspective on Psoriatic Arthritis: What more can Rheumatologists do to Optimise Disease Management? - European Medical Journal
Dapsa Eng | PDF
